McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan authored an article entitled, “Patenting Prospects for Cell-Based Therapies” that appears in the September 15, 2017online edition of BioPharm-International. Treatment using cell-based therapies involves significant investment and, therefore, can be expected to have concomitantly significant costs to patients and their insurers. View the article